Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
19.89
+0.64 (3.32%)
Feb 21, 2025, 4:00 PM EST - Market closed
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $35.45 million as of February 21, 2025. Its market cap has increased by 95.86% in one year.
Market Cap
35.45M
Enterprise Value
31.09M
1-Year Change
95.86%
Ranking
Category
Stock Price
$19.89
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $35.45M, a decrease of -39.05%. That is a compound annual growth rate of -21.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2025 | 34.27M | 32.68% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |